Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Tolvaptan
Drug ID BADD_D02246
Description Tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormones (SIADH). FDA approved on May 19, 2009.
Indications and Usage Treatment of symptomatic and resistant to fluid restriction euvolemic or hypervolemic hyponatremia associated with congestive heart failure, SIADH, and cirrhosis.
Marketing Status approved
ATC Code C03XA01
DrugBank ID DB06212
KEGG ID D01213
MeSH ID D000077602
PubChem ID 216237
TTD Drug ID D03KZM
NDC Product Code 31722-869; 59148-088; 60505-4704; 65977-0100; 59148-082; 67877-637; 59148-079; 60505-4318; 60505-4705; 46602-0031; 59148-089; 14501-0066; 31722-868; 59148-083; 46602-0028; 46602-0030; 49884-770; 59148-020; 67877-635; 14501-0085; 57884-0027; 49884-768; 59148-021; 59148-080; 60505-4317; 67877-636; 46602-0027; 46602-0029; 60862-008; 59148-087
UNII 21G72T1950
Synonyms Tolvaptan | 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine | Samsca | OPC 41061 | OPC-41061 | OPC41061
Chemical Information
Molecular Formula C26H25ClN2O3
CAS Registry Number 150683-30-0
SMILES CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Body temperature increased13.15.01.001--Not Available
Cardiac failure02.05.01.0010.002076%
Cardiac failure acute02.05.01.0050.000058%Not Available
Cardiac failure congestive02.05.01.0020.000523%Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000145%Not Available
Cardiomegaly02.04.02.0010.000058%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.0030.000145%Not Available
Cerebral infarction24.04.06.002; 17.08.01.0040.000523%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Chills08.01.09.001; 15.05.03.016--
Cholangitis09.02.01.0020.000087%Not Available
Cholecystitis09.03.01.0010.000087%
Circulatory collapse24.06.02.0010.000116%Not Available
Colitis ischaemic24.04.08.012; 07.08.01.004--Not Available
Colon cancer16.13.01.001; 07.21.01.0010.000058%Not Available
Coma hepatic17.02.09.002; 09.01.03.0050.000058%Not Available
Condition aggravated08.01.03.0040.000855%Not Available
Conjunctival haemorrhage24.07.05.001; 06.07.01.0010.000058%Not Available
Constipation07.02.02.001--
Coronary artery disease24.04.04.006; 02.02.01.0010.000058%Not Available
Crying19.04.02.002; 17.02.05.013; 12.02.11.001; 08.01.03.0050.000058%Not Available
Deafness04.02.01.0010.000058%Not Available
Death08.04.01.0010.008462%
Dehydration14.05.05.0010.001867%
Delirium19.13.02.0010.000145%
Dementia17.03.01.001; 19.20.02.0010.000087%Not Available
Demyelination17.16.02.0010.000087%Not Available
Depressed level of consciousness17.02.04.0020.000116%
Depressed mood19.15.02.0010.000489%Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 10 Pages